Item does not contain fulltextTraditional diagnostic methods such as clinical assessment, histopathological examination and imaging techniques are limited in their capacity to provide information on prognosis and treatment choice of head and neck cancer. In recent years, molecular techniques have been developed that enabled us to get more insight into the molecular biological cellular pathways underlying tumor progression and metastasis. Correlation of these molecular changes with clinical events has been explored. However, consistently useful markers have not been identified yet, although many promising developments are in progress. It may be expected that in the near future, molecular markers will be useful for clinical purposes. In this ...
Recent advances in genomic technology, in particular gene expression profiling, may elucidate novel ...
Abstract: For most patients with head and neck squamous cell cancer, a treatment decision concerning...
For most patients with head and neck squamous cell cancer, a treatment decision concerning the neck ...
Abstract: Initial cancer evaluation includes assessment of histologic appearance, tumor grading, ass...
BACKGROUND: The aim of this article is to review recent developments in the biological understanding...
Present therapy of head and neck cancer patients includes surgical procedures, radiotherapy and some...
Abstract: Background. The aim of this article is to review recent developments in the biological und...
Head and neck cancer affects nearly 750,000 patients, with more than 300,000 deaths annually. Advanc...
Of all human cancers, HNSCC is the most distressing affecting pain, disfigurement, speech and the ba...
Head and neck squamous cell carcinoma (HNSCC) is a common malignancy that continues to be difficult ...
Head and neck cancers are a heterogeneous group of neoplasms, affecting an ever increasing global po...
Head and neck cancers encompass a heterogeneous group of tumours that, in general, are biologically ...
Current and emerging biomarkers in primary head and neck carcinoma have diagnostic, prognostic, and ...
Overall survival of head and neck squamous cell carcinoma patients on the whole has not dramatically...
Head and neck cancers encompass a heterogeneous group of tumours that, in general, are biologically ...
Recent advances in genomic technology, in particular gene expression profiling, may elucidate novel ...
Abstract: For most patients with head and neck squamous cell cancer, a treatment decision concerning...
For most patients with head and neck squamous cell cancer, a treatment decision concerning the neck ...
Abstract: Initial cancer evaluation includes assessment of histologic appearance, tumor grading, ass...
BACKGROUND: The aim of this article is to review recent developments in the biological understanding...
Present therapy of head and neck cancer patients includes surgical procedures, radiotherapy and some...
Abstract: Background. The aim of this article is to review recent developments in the biological und...
Head and neck cancer affects nearly 750,000 patients, with more than 300,000 deaths annually. Advanc...
Of all human cancers, HNSCC is the most distressing affecting pain, disfigurement, speech and the ba...
Head and neck squamous cell carcinoma (HNSCC) is a common malignancy that continues to be difficult ...
Head and neck cancers are a heterogeneous group of neoplasms, affecting an ever increasing global po...
Head and neck cancers encompass a heterogeneous group of tumours that, in general, are biologically ...
Current and emerging biomarkers in primary head and neck carcinoma have diagnostic, prognostic, and ...
Overall survival of head and neck squamous cell carcinoma patients on the whole has not dramatically...
Head and neck cancers encompass a heterogeneous group of tumours that, in general, are biologically ...
Recent advances in genomic technology, in particular gene expression profiling, may elucidate novel ...
Abstract: For most patients with head and neck squamous cell cancer, a treatment decision concerning...
For most patients with head and neck squamous cell cancer, a treatment decision concerning the neck ...